Barclays PLC Scholar Rock Holding Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Barclays PLC holds 165,449 shares of SRRK stock, worth $6.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

165,449

Previous 165,449 -0.0%

Holding current value

$6.82 Million

Previous $1.32 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$7.63 - $9.71 $641,820 - $816,785	84,118 Added 103.43%	165,449 $1.32 Million
Q2 2024 Aug 14, 2024	BUY	$7.84 - $16.79 $9,643 - $20,651	1,230 Added 1.54%	81,331 $678,000
Q1 2024 May 15, 2024	SELL	$13.2 - $17.76 $738,513 - $993,636	-55,948 Reduced 41.12%	80,101 $1.42 Million
Q4 2023 Feb 15, 2024	BUY	$6.52 - $20.32 $676,326 - $2.11 Million	103,731 Added 320.97%	136,049 $2.56 Million
Q3 2023 Nov 07, 2023	BUY	$6.02 - $7.76 $74,702 - $96,293	12,409 Added 62.33%	32,318 $230,000
Q2 2023 Aug 03, 2023	BUY	$5.79 - $9.11 $19,309 - $30,381	3,335 Added 20.12%	19,909 $149,000
Q1 2023 May 04, 2023	SELL	$7.36 - $12.72 $126,974 - $219,445	-17,252 Reduced 51.0%	16,574 $132,000
Q4 2022 Feb 13, 2023	BUY	$7.02 - $9.76 $149,540 - $207,907	21,302 Added 170.09%	33,826 $307,000
Q3 2022 Nov 03, 2022	BUY	$5.33 - $11.3 $66,747 - $141,509	12,523 Added 1252300.0%	12,524 $87,000
Q2 2022 Aug 12, 2022	SELL	$4.66 - $13.96 $21,860 - $65,486	-4,691 Reduced 99.98%	1 $0
Q1 2022 May 16, 2022	SELL	$11.89 - $24.68 $384,546 - $798,200	-32,342 Reduced 87.33%	4,692 $60,000
Q4 2021 Feb 14, 2022	BUY	$24.14 - $35.18 $524,127 - $763,828	21,712 Added 141.7%	37,034 $919,000
Q3 2021 Nov 09, 2021	BUY	$27.38 - $42.21 $185,253 - $285,592	6,766 Added 79.08%	15,322 $506,000
Q2 2021 Aug 13, 2021	SELL	$26.34 - $46.62 $389,937 - $690,162	-14,804 Reduced 63.37%	8,556 $247,000
Q1 2021 May 13, 2021	BUY	$45.96 - $68.02 $641,371 - $949,219	13,955 Added 148.38%	23,360 $1.18 Million
Q4 2020 Feb 11, 2021	SELL	$13.72 - $51.57 $43,218 - $162,445	-3,150 Reduced 25.09%	9,405 $456,000
Q3 2020 Nov 12, 2020	BUY	$10.54 - $18.47 $242 - $424	23 Added 0.18%	12,555 $222,000
Q2 2020 Aug 12, 2020	BUY	$10.37 - $20.64 $69,510 - $138,349	6,703 Added 114.99%	12,532 $228,000
Q1 2020 May 13, 2020	SELL	$9.63 - $17.14 $113,961 - $202,834	-11,834 Reduced 67.0%	5,829 $71,000
Q4 2019 Feb 10, 2020	BUY	$7.2 - $13.2 $64,454 - $118,166	8,952 Added 102.77%	17,663 $233,000
Q3 2019 Nov 14, 2019	SELL	$8.95 - $15.72 $11,509 - $20,215	-1,286 Reduced 12.86%	8,711 $78,000
Q2 2019 Aug 14, 2019	BUY	$14.61 - $22.45 $84,548 - $129,918	5,787 Added 137.46%	9,997 $159,000
Q1 2019 May 15, 2019	BUY	$14.24 - $22.28 $46,507 - $72,766	3,266 Added 345.97%	4,210 $79,000
Q4 2018 Feb 14, 2019	SELL	$17.86 - $28.77 $24,753 - $39,875	-1,386 Reduced 59.48%	944 $22,000
Q3 2018 Nov 14, 2018	BUY	$13.39 - $26.25 $31,198 - $61,162	2,330 New	2,330 $60,000

Others Institutions Holding SRRK

# of Institutions

175

Shares Held

75.6M

Call Options Held

585K

Put Options Held

862K

View Full List

About Scholar Rock Holding Corp

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.13B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

More about SRRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account